StockStory.org on MSN

Herbalife (NYSE:HLF) Beats Q3 Sales Expectations, Stock Soars

Health and wellness products company Herbalife (NYSE:HLF) announced in Q3 CY2025, with sales up 2.7% year on year to $1.27 ...

Biohaven sinks as FDA declines to approve lead drug

Biohaven (BHVN) stock plunges as the FDA declines to approve its lead drug Vyglxia (troriluzole) targeted at spinocerebellar ...